Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: Is severity assessment beyond psoriasis area and severity index a necessity? [13]

British Journal of Dermatology

Volumn 156, Issue 4, 2007, Pages 771-772

  Van De Kerkhof, P C M ^a   Mrowietz, U ^b   Segaert, S ^c   Kragballe, K ^d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPSORIASIS AGENT; BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; INFLIXIMAB;

BODY SURFACE; DERMATITIS; DERMIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EPIDERMIS; HUMAN; INFLAMMATORY INFILTRATE; KERATINOCYTE; LETTER; NEUTROPHIL; NONHODGKIN LYMPHOMA; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; SCORING SYSTEM; VASCULITIS;

ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; BIOLOGICAL PRODUCTS; CALCITRIOL; DERMATOLOGIC AGENTS; DRUG ADMINISTRATION ROUTES; HUMANS; PSORIASIS; SEVERITY OF ILLNESS INDEX; SKIN DISEASES; TREATMENT OUTCOME;

EID: 33947356311     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07747.x     Document Type: Letter

References (3)

1. Anstey AV, Kragballe K. Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment. Int J Dermatol 2006; 45:970-5.
2. van de Kerkhof PCM, Kragballe K. Psoriasis: severity assessment in clinical practice. Conclusions from workshop discussions and a prospective multicentre survey of psoriasis severity. Eur J Dermatol 2006; 16:167-71.
3. Kirby B, Fortune DG, Bhushan M et al. The Salford Psoriasis Index: an holistic measure of psoriasis severity. Br J Dermatol 2000; 142:728-32.